POZEN Inc. (NASDAQ: POZN) 34% HIGHER; Company signed an exclusive global collaboration agreement with AstraZeneca (NYSE: AZN) for the co-development ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE